In breast cancer cell lines, tumor cells are not only able to pass a key molecule that mediates multidrug resistance, i.e., P-glycoprotein (P-gp), conferring the recipient cells with multidrug resistance, but also can regulate the expression level of P-gp by passing miRNA in order to enhance congenital resistance [94–96]. The gene discussed is PGP; the disease is breast carcinoma.